Arkolith/Insider Trading/CATX/Form 4

Spoor Johan M.

CEO, DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Nov 26, 2024
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2024Buy(P)7K$3.80$25K67K
Nov 25, 2024Buy(P)15K$3.78$55K152K
Nov 25, 2024Buy(P)5K$3.80$21K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-130754) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML